Skip to main content
Premium Trial:

Request an Annual Quote

Pairings : Apr 8, 2009


Jonathan Lord, Humana's chief innovation officer, will be CEO of consumer genomics firm Navigenics as of May 1. Prior to Humana, Lord was president of Health Dialog and chief operating officer of the American Hospital Association.

Lord will take over for Mari Baker, who served as Navigenics' CEO and president since 2007. Baker announced she was leaving Navigenics in February to become CEO of an entertainment and video game company called Playfirst.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.